症状性对侧颈动脉闭塞CEA与CAS系统评价的方法学质量及重叠性概览
该概览评价比较症状性对侧颈动脉闭塞患者CEA与CAS的系统评价方法学质量及原始研究重叠度。检索至2025年6月,纳入9篇系统评价(2008–2021年)源于86项原始研究。AMSTAR-2评定8篇极低、1篇低置信度,总体校正覆盖面积16.7%提示证据高度重叠,未显示CEA或CAS一致的方法学稳健优势。
要点
- 现有比较CEA与CAS的系统评价方法学质量普遍低下,AMSTAR-2多为极低置信度。
- 86项原始研究被多篇综述重复使用,校正覆盖面积16.7%提示证据高度重叠。
- 现有数据不足以支持在该高危人群中优先选择CEA或CAS。
核心结论
- 症状性对侧颈动脉闭塞比较CEA与CAS的二次证据以低置信度综述和重叠的观察性队列为主,未证明任一方法学稳健的优越性。
研究设计与样本
- 检索PubMed和Embase(2025年6月),纳入比较成人症状性CCO或可提取症状性CCO亚组数据的CEA与CAS系统评价和荟萃分析。
- 两名评价者独立筛选、提取数据并用AMSTAR-2评估方法学质量,用校正覆盖面积(CCA)评估原始研究重叠。
主要发现
- 共纳入9篇系统评价和荟萃分析(发表于2008至2021年),源自86项独特原始研究。
- AMSTAR-2评定8篇(88.9%)为极低置信度,1篇(11.1%)为低置信度。
- 86项原始研究的总体CCA为16.7%,提示证据基础高度重叠。
- 临床结局报告异质,且常缺乏提取的原始事件率。
关键数值与推荐
- AMSTAR-2评定:极低置信度8篇(88.9%),低置信度1篇(11.1%)。
- 原始研究总体校正覆盖面积(CCA)为16.7%。
- 主要局限包括方案透明度缺乏、检索策略报告不完整、无排除研究清单及偏倚风险评估未充分整合入解释。
临床怎么用
- 当前数据不能支持在该高危群体中优先选择CEA或CAS,决策应基于患者解剖、手术风险和团队经验。
- 临床解读现有综述一致性时需警惕原始研究重叠,一致性不等于确证。
局限性
- 纳入综述方法学质量普遍极低,限制证据可靠性。
- 原始研究多为观察性队列且结局报告异质,常缺乏原始事件率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Symptomatic contralateral carotid occlusion (CCO) is considered a high-risk scenario for carotid revascularization, yet the comparative evidence for carotid endarterectomy (CEA) versus carotid artery stenting (CAS) is largely derived from observational data and repeatedly synthesized in systematic reviews. This research aimed to assess reviews appraising the methodological quality of these evidence syntheses and quantify overlap of included primary studies. METHODS: PubMed and Embase were searched (June 2025) for systematic reviews and meta-analyses comparing CEA versus CAS in adults with symptomatic CCO or reporting extractable symptomatic CCO subgroup data. Two reviewers independently screened studies, extracted data, and assessed methodological quality using AMSTAR-2. Overlap among primary studies across reviews was evaluated using the corrected covered area (CCA). RESULTS: Nine systematic reviews and meta-analyses (published from 2008 to 2021) derived from 86 unique primary studies were included. Overall confidence in review findings was poor: 8 (88.9%) were rated critically low and 1 (11.1%) low by AMSTAR-2. Major limitations included lack of protocol transparency, incomplete reporting of search strategies, absence of excluded-study lists, and insufficient integration of risk-of-bias assessments into interpretation. Across the 86 unique primary studies, the overall CCA was 16.7%, indicating high overlap in the evidence base. Clinical outcome reporting was heterogeneous and often lacked extracted raw event rates. Across reviews, no consistent, methodologically robust superiority of CEA or CAS was demonstrated. CONCLUSIONS: The secondary evidence comparing CEA and CAS in symptomatic CCO is dominated by low-confidence reviews and overlapping assessed evidence from observational cohorts. Future comparative studies and systematic reviews should prioritize standardized outcome reporting, transparent methods, and explicit management of overlapping primary evidence.Clinical ImpactThis overview shows that existing comparisons of CEA versus CAS in symptomatic contralateral carotid occlusion rest on weak, repetitive evidence. Most reviews scored poorly on AMSTAR-2, and the same retrospective studies were reused across multiple reviews, so agreement between them does not mean the findings are truly confirmed. For clinicians, this means current data cannot support choosing one procedure over the other for this high-risk group. Decisions should still be based on the patient's anatomy, surgical risk, and the treating team's experience. Higher-quality, independent studies and more transparent reviews are needed to clarify this question.
引用
- Ruffini ML, Souza AM, Gomes EG, et al. Methodological Quality and Overlap of Systematic Reviews Comparing Carotid Endarterectomy versus Carotid Artery Stenting in Symptomatic Contralateral Carotid Occlusion: An Overview of Reviews. J Endovasc Ther. 2026. PMID: 42781850. doi:10.1177/15266028261489512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。